|
Volumn 37, Issue 6, 2005, Pages 2853-2855
|
Corticosteroid withdrawal in simultaneous pancreas-kidney transplantation: A 3-year report
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
CYCLOSPORIN;
IMMUNOSUPPRESSIVE AGENT;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
RECOMBINANT ANTIBODY;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ACUTE GRAFT REJECTION;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORTICOSTEROID THERAPY;
DISEASE SEVERITY;
DRUG DOSE REGIMEN;
DRUG SAFETY;
DRUG WITHDRAWAL;
FEASIBILITY STUDY;
FOLLOW UP;
GRAFT FAILURE;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MICROEMULSION;
MULTICENTER STUDY;
PANCREAS;
PANCREAS TRANSPLANTATION;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
SHORT COURSE THERAPY;
SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION;
STATISTICAL SIGNIFICANCE;
SURGICAL PATIENT;
TREATMENT OUTCOME;
|
EID: 25144437053
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2005.05.026 Document Type: Article |
Times cited : (8)
|
References (3)
|